Lenti-human-UBDUB-gRNA-puromycin-IRES-CFP Citations (2)

Originally described in: Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens.
Wright S, Hu J, Wang H, Hyle J, Zhang Y, Du G, Konopleva MY, Kornblau SM, Djekidel MN, Rosikiewicz W, Xu B, Lu R, Yang JJ, Li C Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2220134120. doi: 10.1073/pnas.2220134120. Epub 2023 Apr 10. PubMed Journal

Articles Citing Lenti-human-UBDUB-gRNA-puromycin-IRES-CFP

Showing 1 to 2 of 2 entries

Show entries

Search table:

Articles
ASB6 as an Independent Prognostic Biomarker for Colorectal Cancer Progression Involves Lymphatic Invasion and Immune Infiltration. Hu Q, Chen Y, Zhou Q, Deng S, Mu B, Tang J. J Cancer. 2024 Mar 17;15(9):2712-2730. doi: 10.7150/jca.93066. eCollection 2024. PubMed
Interrogating bromodomain inhibitor resistance in KMT2A-rearranged leukemia through combinatorial CRISPR screens. Wright S, Hu J, Wang H, Hyle J, Zhang Y, Du G, Konopleva MY, Kornblau SM, Djekidel MN, Rosikiewicz W, Xu B, Lu R, Yang JJ, Li C. Proc Natl Acad Sci U S A. 2023 Apr 18;120(16):e2220134120. doi: 10.1073/pnas.2220134120. Epub 2023 Apr 10. PubMed Associated Plasmids Lenti-human-UBDUB-gRNA-puromycin-IRES-CFP

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.